Eling Pharmaceutical announced that the company recently received the Chinese medicine innovative drug “Pediatric Lianhua Cold Particles” and “Drug Registration Certificate” approved and issued by the State Drug Administration. The drug approval number is Sinopharm Standard Z20260006. The registration classification is Class 1.1 of traditional Chinese medicine. The dosage form is granules, and the drug is valid for 36 months. This drug is an innovative traditional Chinese medicine independently developed by the company. Its function is to clear heat, relieve symptoms, release fever from the lungs, and relieve fever, and is used for wind fever and colds in children aged 4 to 12. The company has independent and complete intellectual property rights for this drug, which is not expected to have a significant impact on the company's recent business performance, and will begin related production and sales work as soon as possible.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.